http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TN-2019000054-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
filingDate 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_077830f1ba82f044d887aeeb3c726261
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dcfaf8098edd3487186355d9f0a239e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b45286a84b69ecab6b1e9821163d3e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a541e11af0fd975d870d5e7cc8ed2bba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21921663cfbd1e757101b6370030b78e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb89d87d63348a78bf26ee7ab729d03f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c48d2913de9844046aee33159d61b39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f80f6f8dda63d7014f1a6837471129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b7fa6d40d4bbb139d3e6e86d85a323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d40b089bb693fa18a95c378e1ddb8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abee21527735efffdd9f4dc2079db060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8f3b2711c66c2496987af44f1078e9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_041c7dd6c869b06cc143a20596668a85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05d4398ae76681ec115e97a60e4aeb00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dafb8887a690b8e61c6fa549533f3c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c14b89436454d3e04296263c906a6013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_294fb52ddd898fe568b4150cf93b9501
publicationDate 2020-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TN-2019000054-A1
titleOfInvention Pyrazolopyridine derivative having glp-1 receptor agonist effect
abstract The present invention provides a compound having the basic structure shown by Formula (1) in which the indole ring and the pyrazolopyridine structure is bound through a substituent, a salt thereof or a solvate of either the compound or a salt of the compound, as well as a preventative agent or a therapeutic agent for non-insulin-dependent diabetes mellitus (Type 2 diabetes) or obesity containing such compound, salt or solvate as an active ingredient.
priorityDate 2016-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426246568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21643653

Total number of triples: 58.